Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site — Torrance, California

Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site is a clinical research site located in Torrance, California, United States 90502.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site has participated in 2 clinical trials.

Therapeutic areas: Hodgkin's Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Hodgkin Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Torrance

Browse all research sites in California · View every site in Torrance

• Little Company of Mary Hospital
• Harbor University of California Los Angeles Center CRS
• University of California at Los Angeles
• University of California
• Del Amo Hospital
• Jonathan Jaques Children's Cancer Center at Miller Children's Hospital
• 603, Harbor University of California Los Angeles Center CRS
• Harbor Hospital / UCLA
• University of California, Los Angeles-Harbor
• Harbor-University of California Los Angeles Medical Center
• Good Samaritan Hospital
• Torrance Memorial Hospital

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site?

Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site conducted?

Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site has 2 clinical trials on record. Their work covers Hodgkin's Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Hodgkin Lymphoma.

Is Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site accredited by Crixeo Clinical Trials?

Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.